Heron Therapeutics Inc (HRTX)
3.49
+0.08
(+2.35%)
USD |
NASDAQ |
Jun 28, 16:00
3.50
+0.01
(+0.29%)
After-Hours: 20:00
Heron Therapeutics Research and Development Expense (Annual): 55.90M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 55.90M |
| December 31, 2022 | 107.51M |
| December 31, 2021 | 130.82M |
| December 31, 2020 | 174.53M |
| December 31, 2019 | 167.38M |
| December 31, 2018 | 140.03M |
| December 31, 2017 | 138.58M |
| December 31, 2016 | 103.12M |
| December 31, 2015 | 61.18M |
| December 31, 2014 | 54.83M |
| December 31, 2013 | 32.52M |
| December 31, 2012 | 15.17M |
| December 31, 2011 | 8.207M |
| December 31, 2010 | 7.264M |
| December 31, 2009 | 7.796M |
| Date | Value |
|---|---|
| December 31, 2008 | 19.51M |
| December 31, 2007 | 19.36M |
| December 31, 2006 | 15.24M |
| December 31, 2005 | 10.30M |
| December 31, 2004 | 11.50M |
| December 31, 2003 | 8.66M |
| December 31, 2002 | 6.699M |
| December 31, 2001 | 7.348M |
| December 31, 2000 | 3.713M |
| December 31, 1999 | 2.50M |
| December 31, 1998 | 2.40M |
| December 31, 1997 | 3.70M |
| December 31, 1996 | |
| December 31, 1995 | 4.10M |
| December 31, 1994 | 6.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
55.90M
Minimum
2023
174.53M
Maximum
2020
127.23M
Average
130.82M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Arcutis Biotherapeutics Inc | 110.58M |
| Marinus Pharmaceuticals Inc | 99.39M |
| Amgen Inc | 4.784B |
| Ionis Pharmaceuticals Inc | 899.62M |
| Ligand Pharmaceuticals Inc | 24.54M |